Amg National Trust Bank Contrafect Corp Transaction History

Amg National Trust Bank

  • $3.7 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021
BUY
$3.58 - $4.9 $3,694 - $5,056
1,032 Added 3.29%
32,432 $143,000
Q1 2021

May 11, 2021
BUY
$4.46 - $6.68 $140,044 - $209,752
31,400 New
31,400 $151,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Amg National Trust Bank Portfolio

Follow Amg National Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amg National Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amg National Trust Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email